Analytical studies on photochemical behavior of phototoxic substances; effect of detergent additives on singlet oxygen generation

Pharmaceutical Research

Volumn 25, Issue 4, 2008, Pages 861-868

  Onoue, Satomi ^a,b   Yamauchi, Yukinori ^a   Kojima, Takashi ^a   Igarashi, Naoko ^a   Tsuda, Yoshiko ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Photosensitizer; Phototoxicity; Singlet oxygen; Surfactant; UV

Indexed keywords

4 NITROSO DIMETHYLANILINE; AMIODARONE; ANILINE DERIVATIVE; ANTHRACENE; CHLOROTHIAZIDE; DETERGENT; DICLOFENAC; DODECYL SULFATE SODIUM; DRUG ADDITIVE; FUROSEMIDE; HALOPERIDOL; IMIPRAMINE; LAURATE SODIUM; LAURIC ACID; OMEPRAZOLE; PHOTOSENSITIZING AGENT; POLYSORBATE 20; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; SULISOBENZONE; TAMOXIFEN;

ANALYTIC METHOD; ARTICLE; BLEACHING; CONCENTRATION (PARAMETERS); ELECTRICITY; LIGHT EXPOSURE; METHODOLOGY; MICELLE; MICROENVIRONMENT; MONITORING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOCHEMISTRY; PHOTOREACTIVITY; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL;

ANIMALS; DERMATITIS, PHOTOTOXIC; DETERGENTS; ELECTROSTATICS; HUMANS; LAURIC ACIDS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; PHOTOSENSITIZING AGENTS; POLYSORBATES; SINGLET OXYGEN; SODIUM DODECYL SULFATE; SOLUBILITY; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 43349089094     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9383-4     Document Type: Article

References (33)

1. A. M. Kligman and R. Breit. The identification of phototoxic drugs by human assay. J. Invest. Dermatol. 51:90-99 (1968).
2. N. J. Wainwright, P. Collins, and J. Ferguson. Photosensitivity associated with antibacterial agents. Drug Saf. 9:437-440 (1993).
3. J. A. Wiebe and D. E. Moore. Oxidation photosensitized by tetracyclines. J. Pharm. Sci. 66:186-189 (1977).
4. F. Vargas, I. Martinez Volkmar, J. Sequera, H. Mendez, J. Rojas, G. Fraile, M. Velasquez, and R. Medina. Photodegradation and phototoxicity studies of furosemide. Involvement of singlet oxygen in the photoinduced hemolysis and lipid peroxidation. J. Photochem. Photobiol. B 42:219-225 (1998).
5. L. Becker, B. Eberlein-Konig, and B. Przybilla. Phototoxicity of non-steroidal anti-inflammatory drugs: in vitro studies with visible light. Acta Derm. Venereol. 76:337-340 (1996).
6. P. Ball and G. Tillotson. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf. 13:343-358 (1995).
7. G. Viola, G. Miolo, D. Vedaldi, and F. Dall'Acqua. In vitro studies of the phototoxic potential of the antidepressant drugs amitriptyline and imipramine. Farmaco 55:211-218 (2000).
8. N. Canudas and C. Contreras. Isolation and identification of the photodegradation products of the photosensitizing antidepressant drug clomipramine. Phototoxicity studies on erythrocytes. Pharmazie 57:405-408 (2002).
9. J. H. Epstein and B. U. Wintroub. Photosensitivity due to drugs. Drugs 30:42-57 (1985).
10. C. Arlett, L. Earl, J. Ferguson, N. Gibbs, J. Hawk, L. Henderson, B. Johnson, W. Lovell, H. D. Menage, S. Navaratnam, et al. British Photodermatology Group Workshop. Predictive in vitro methods for identifying photosensitizing drugs: a report. Br. J. Dermatol. 132:271-274 (1995).
11. E. Selvaag. Evaluation of phototoxic properties of oral antidiabetics and diuretics. Photohemolysis model as a screening method for recognizing potential photosensitizing drugs. Arzneimittelforschung 47:1031-1034 (1997).
12. J. C. Beani, R. Gautron, P. Amblard, F. Bastrenta, L. Harrouch, P. Jardon, and J. L. Reymond. Screening for drug photosensitization activity by measuring the variations in oxygen consumption of Bacillus subtilis. Photodermatology 2:101-106 (1985).
13. P. Portes, M. J. Pygmalion, E. Popovic, M. Cottin, and M. Mariani. Use of human reconstituted epidermis Episkin for assessment of weak phototoxic potential of chemical compounds. Photodermatol. Photoimmunol. Photomed. 18:96-102 (2002).
14. H. Spielmann, M. Liebsch, B. Doring, and F. Moldenhauer. First results of an EC/COLIPA validation project of in vitro phototoxicity testing methods. Altex 11:22-31 (1994).
15. S. Onoue and Y. Tsuda. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm. Res. 23:156-164 (2006).
16. C. S. Foote. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54:659 (1991).
17. D. E. Moore. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 25:345-372 (2002).
18. A. M. Sautereau, C. Tournaire, M. Suares, J. F. Tocanne, and N. Paillous. Interactions of amiodarone with model membranes and amiodarone-photoinduced peroxidation of lipids. Biochem. Pharmacol. 43:2559-2566 (1992).
19. M. Budai, Z. Szabo, A. Zimmer, M. Szogyi, and P. Grof. Studies on molecular interactions between nalidixic acid and liposomes. Int. J. Pharm. 279:67-79 (2004).
20. I. Kraljic and S. E. Mohsni. A new method for the detection of singlet oxygen in aqueous solutions. Photochem. Photobiol. 28:577-581 (1978).
21. C. O. Rangel-Yagui, A. Pessoa Jr., and L. C. Tavares. Micellar solubilization of drugs. J. Pharm. Pharm. Sci. 8:147-165 (2005).
22. M. Monici, N. Mulinacci, P. Baglioni, and F. F. Vincieri. Flavone photoreactivity. UV-induced reactions in organic solvents and micellar systems. J. Photochem. Photobiol. B 20:167-172 (1993).
23. J. E. Weinstein and K. D. Polk. Phototoxicity of anthracene and pyrene to glochidia of the freshwater mussel Utterbackia imbecillis. Environ. Toxicol. Chem. 20:2021-2028 (2001).
24. S. Encinas, F. Bosca, and M. A. Miranda. Phototoxicity associated with diclofenac: a photophysical, photochemical, and photobiological study on the drug and its photoproducts. Chem. Res. Toxicol. 11:946-952 (1998).
25. G. P. Thami, S. Kaur, and A. J. Kanwar. Delayed reactivation of haloperidol induced photosensitive dermatitis by methotrexate. Postgrad. Med. J. 78:116-117 (2002).
26. J. Jagger. Solar-UV actions on living cells. Praeger Scientific, New York, 1985.
27. Y. N. Abdiche and D. G. Myszka. Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal. Biochem. 328:233-243 (2004).
28. S. Kobayashi, K. Takeshima, C. B. Park, S. C. Kim, and K. Matsuzaki. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39:8648-8654 (2000).
29. P. W. Wertz. Epidermal lipids. Semin. Dermatol. 11:106-113 (1992).
30. H. J. Yardley and R. Summerly. Lipid composition and metabolism in normal and diseased epidermis. Pharmacol. Ther. 13:357-383 (1981).
31. M. Fresta, S. Guccione, A. R. Beccari, P. M. Furneri, and G. Puglisi. Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin. Bioorg. Med. Chem. 10:3871-3889 (2002).
32. J. P. Martin Jr., K. Colina, and N. Logsdon. Role of oxygen radicals in the phototoxicity of tetracyclines toward Escherichia coli B. J. Bacteriol. 169:2516-2522 (1987).
33. K. Hirakawa, S. Kawanishi, and T. Hirano. The mechanism of guanine specific photooxidation in the presence of berberine and palmatine: activation of photosensitized singlet oxygen generation through DNA-binding interaction. Chem. Res. Toxicol. 18:1545-1552 (2005).